Could Digital Medicines Improve Access For All?
Digital medicines could provide a new roadmap to reimbursement and regulatory approval.
Close log in window
A universal standard for real-world evidence no longer seems quixotic. But how are companies going to do it?
Both pharma and payers say they need to talk more, but are they really listening?
Universal standards for real-world evidence are closer than you might think
